Search Within

David Hyman

  1. "GSK Faculty"
Formats
  1. Journal Article (105)
  2. Meeting Abstract (99)
  3. Research Letter (3)
  4. Editorial (2)
  5. Review (1)
Groups
  1. Department of Medicine (210)
  2. Early Drug Development Service (210)
  3. GSK Faculty (210)
  4. Solid Tumor Oncology Division (210)
  5. Human Oncology and Pathogenesis Program (167)
  6. Department of Pathology and Laboratory Medicine (158)

More Groups

People
  1. David Solit (107)
  2. Michael Berger (105)
  3. Marc Ladanyi (81)
  4. Ahmet Zehir (73)
  5. Maria Arcila (55)
  6. Jose Baselga (54)

More People

Years
  1. 2022 (2)
  2. 2021 (5)
  3. 2020 (32)
  4. 2019 (39)
  5. 2018 (37)
  6. 2017 (36)

More Years

Publications
  1. Journal of Clinical Oncology (41)
  2. Cancer Research (22)
  3. Blood (16)
  4. Clinical Cancer Research (15)
  5. Cancer Discovery (14)
  6. Annals of Oncology (8)

More Publications

Publishers
  1. American Association for Cancer Research (55)
  2. American Society of Clinical Oncology (49)
  3. Nature Publishing Group (19)
  4. American Society of Hematology (17)
  5. Oxford University Press (10)
  6. American Medical Association (7)

More Publishers

Results (210)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The efficacy of vemurafenib in Erdheim-Chester disease and Langerhans cell histiocytosis: Preliminary results from VE-basket study
    Meeting Abstract

    Hyman, D. M.; Diamond, E.; Subbiah, V.; Blay, J. Y.; Lockhart, A. C.; Abdel-Wahab, O.; Sirzén, F.; Veronese, M. L.; Laserre, S. F.; Elez, E.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Unraveling the molecular basis of Langerhans and non-Langerhans cell histiocytic neoplasms through whole exome sequencing
    Meeting Abstract

    Durham, B.; Ma, J.; Kim, E.; Choi, J. K.; Campbell, P.; Estrada-Veras, J.; Walsh, M. P.; Lacouture, M. E.; Chung, Y. R.; Nakitandwe, J.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • The performance of BRCA1 immunohistochemistry for detecting germline, somatic, and epigenetic BRCA1 loss in high-grade serous ovarian cancer
    Journal Article

    Meisel, J. L.; Hyman, D. M.; Garg, K.; Zhou, Q.; Dao, F.; Bisogna, M.; Gao, J.; Schultz, N. D.; Grisham, R. N.; Phillips, M.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease
    Journal Article

    Emile, J. F.; Diamond, E. L.; Hélias-Rodzewicz, Z.; Cohen-Aubart, F.; Charlotte, F.; Hyman, D. M.; Kim, E.; Rampal, R.; Patel, M.; Ganzel, C.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease
    Journal Article

    Diamond, E. L.; Dagna, L.; Hyman, D. M.; Cavalli, G.; Janku, F.; Estrada-Veras, J.; Ferrarini, M.; Abdel-Wahab, O.; Heaney, M. L.; Scheel, P. J.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • BRAF V600E mutation and clonal evolution in a patient with relapsed refractory myeloma with plasmablastic differentiation
    Journal Article

    Bohn, O. L.; Hsu, K.; Hyman, D. M.; Pignataro, D. S.; Giralt, S.; Teruya-Feldstein, J.
    Clinical Lymphoma, Myeloma and Leukemia (2014)

    Fulltext@MSK | Save
  • Detection of an NRAS mutation in Erdheim-Chester disease
    Journal Article

    Diamond, E. L.; Abdel-Wahab, O.; Pentsova, E.; Borsu, L.; Chiu, A.; Teruya-Feldstein, J.; Hyman, D. M.; Rosenblum, M.
    Blood (2013)

    Fulltext@MSK | Save
  • BRAF Mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer
    Journal Article

    Grisham, R. N.; Iyer, G.; Garg, K.; DeLair, D.; Hyman, D. M.; Zhou, Q.; Iasonos, A.; Berger, M. F.; Dao, F.; Spriggs, D. R.; more...
    Cancer (2013)

    Fulltext@MSK | Save
  • A comprehensive analysis of BRAF and KRAS mutation status in low-grade serous (LGS) and serous borderline (SB) ovarian cancer (OC)
    Meeting Abstract

    Grisham, R. N.; Garg, K.; Zhou, Q.; Iasonos, A.; Berger, M. F.; Dao, F.; Hyman, D. M.; Levine, D. A.; Solit, D. B.; Aghajanian, C.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCA1-associated serous ovarian cancer
    Journal Article

    Hyman, D. M.; Zhou, Q.; Iasonos, A.; Grisham, R. N.; Arnold, A. G.; Phillips, M. F.; Bhatia, J.; Levine, D. A.; Aghajanian, C.; Offit, K.; more...
    Cancer (2012)

    Fulltext@MSK | Save